Nuochengjianhua Investor Relations Activity Record List (November 12, 2024)
Nuochengjianhua Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Nuocheng Jianhua: Hong Kong Stock Announcement: Monthly Report on Securities Changes
Hong Kong Stock Announcement: Monthly Statement of Changes in Securities
Nuochengjianhua: Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on holding a performance briefing for the third quarter of 2024
Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on holding a performance briefing for the third quarter of 2024
Nuocheng Jianhua: Hong Kong Stock Announcement: Date of Board Meeting
Hong Kong Stock Announcement: Date of Board Meeting
Announcement on voluntary disclosure of ICP-488 phase II clinical trial results by Nuochengjianhua Pharmaceutical Co., Ltd.
Nuocheng Jianhua: Hong Kong Stock Announcement: Monthly Report on Securities Changes
Hong Kong Stock Announcement: Monthly Statement of Changes in Securities
Nuocheng Jianhua: Hong Kong Stock Announcement: List of Directors and Their Roles and Functions
Nuochengjianhua: Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on the resignation of non-executive directors and independent non-executive directors and the change of members of the Board of Directors Special Committee
Hong Kong Stock Announcement: List of Directors and Their Roles and Functions
Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on the resignation of non-executive directors and independent non-executive directors and the change of members of the special committee of the board
Hong Kong Stock Announcement: 2024 Interim Report
Announcement of Nuocheng Jianhua Pharmaceutical Co., Ltd. on changing the sponsor representative for continuous supervision
China International Finance Corporation\'s inspection opinions on the initial public offering of Nuochengjianhua Pharmaceutical Co., Ltd.\'s strategic placement and listing circulation of restricted shares
Announcement on the initial public offering of Nuochengjianhua Pharmaceutical Co., Ltd., the listing and circulation of restricted shares
Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the progress of clinical trials of obutinib
No Data
No Data